Stock Events

Stock Events

Bioventix

$0.000000

97

+$0.00+0% Monday 00:00

Statistics

Day High

-

Day Low

-

52W High

-

52W Low

-

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

Upcoming

Dividend Payment

Dividend Payment

Dividend Payment

Dividend Payment

Dividends

0%Dividend Yield

Apr 26

$0.95

Nov 25

$1.05

Apr 25

$0.93

Nov 24

$1.10

Apr 24

$0.85

10Y Growth

12.62%

5Y Growth

9.23%

3Y Growth

6.52%

1Y Growth

-1.56%

Earnings

26OctExpected

Q3 2025

Q4 2025

Next

0.87

0.94

1.01

1.07

Expected EPS

0.874962

Actual EPS

N/A

Financials

57.91%Profit Margin

Profitable

2019

2020

2021

2022

2023

2024

17.19MRevenue

9.96MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BVNXF. It's not an investment recommendation.

Legal & General Group

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Abbott Laboratories

Abbott Laboratories offers diagnostic solutions and competes in the antibody space, overlapping with Bioventix's antibody development for diagnostics.

Danaher Corporation, through its subsidiaries, provides professional, medical, industrial, and commercial products and services, including diagnostic solutions that compete with Bioventix.

ResMed Inc. specializes in medical devices for respiratory disorders but also ventures into health diagnostics, indirectly competing with Bioventix's diagnostic technologies.

Bio-Rad Laboratories

Bio-Rad Laboratories, Inc. offers a range of products for the life science research and clinical diagnostics markets, directly competing with Bioventix in the diagnostics sector.

Thermo Fisher Scientific

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, competing with Bioventix in the diagnostics and research market.

Qiagen N.V. provides sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the diagnostics market alongside Bioventix.

Bruker Corporation designs, manufactures, and distributes scientific instruments and analytical and diagnostic solutions, competing with Bioventix in the diagnostics and analytical solutions sector.

Waters Corporation produces analytical instruments, software, and services for the healthcare sector, including diagnostics, competing with Bioventix in the development of diagnostic solutions.

Agilent Technologies

Agilent Technologies, Inc. provides application-focused solutions in the life sciences, diagnostics, and applied chemical markets, competing with Bioventix in the diagnostics and research fields.

About

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment. The company also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

Show more...

CEO

Country

United Kingdom

ISIN

GB00B4QVDF07

WKN

000A113DD

Listings

0 Comments

Share your thoughts

FAQ

What is Bioventix stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Bioventix stocks are traded under the ticker BVNXF.

When is the next Bioventix earnings date?▼

Bioventix is going to release the next earnings report on October 26, 2026.

What were Bioventix earnings last quarter?▼

BVNXF earnings for the last quarter are 0.92 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.

What is Bioventix revenue for the last year?▼

Bioventix revenue for the last year amounts to 17.19M USD.

What is Bioventix net income for the last year?▼

BVNXF net income for the last year is 9.96M USD.

Does Bioventix pay dividends?▼

Yes, BVNXF dividends are paid semi-annual. The last dividend per share was 0.95 USD. As of today, Dividend Yield (FWD)% is 0%.

In which sector is Bioventix located?▼

Bioventix operates in the Other sector.

When did Bioventix complete a stock split?▼

Bioventix has not had any recent stock splits.